𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection

✍ Scribed by Jie Yu; Huiyuan Chen; Helen Horton; Anju Bansal; Julie M. McElrath; Richard Reichman; Paul Goepfert; Xia Jin


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
334 KB
Volume
78
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Recent studies indicate that a defective proliferative response of HIV‐specific CD8+ T cells is associated with the lack of virologic control in chronic HIV infection in humans. The possible mechanisms that might be responsible for the reduced proliferative potential of HIV‐specific CD8+ T cells and conditions conducive to the proliferation of CD8+ T cells were examined in 14 HIV‐infected individuals and 7 HIV‐uninfected controls using CFSE labeling and flow cytometry techniques, and analyzed data using 2 quantitative measurements: the percentages of proliferating CD8+ T cells (Tp), and the maximum number of cell divisions (Dm) after stimulation. It was found that CD8+ T cells from HIV‐infected and ‐uninfected subjects proliferated equally well after polyclonal stimulation by phylohemagglutinin A (PHA); both groups reached a Tp of 92%–96% and a Dm of 5–8. However, in HIV‐infected subjects, proliferation of HIV‐ and CMV‐specific CD8+ T cells was significantly reduced compared to proliferation of CMV‐ specific CD8+ T cells from HIV‐uninfected subjects. These defective proliferative responses of HIV‐ and CMV‐specific CD8+ T cells were restored by the addition of IL‐2 at the time of stimulation. These results may have implications for the design of immune modulation strategies in vivo. J. Med. Virol. 78:1147–1157, 2006. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Different rates of CD4+ and CD8+ T-cell
✍ Laura Caggiari; Stefania Zanussi; Cinzia Crepaldi; Maria Teresa Bortolin; Cristi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

## Abstract ## BACKGROUND Interleukin‐2 (IL‐2) has been used successfully to increase CD4 cell counts in patients who are human immunodeficiency virus (HIV) positive. The mechanisms involved in this phenomenon are unknown. We hypothesized that a differential proliferation rate of CD4+ compared wit